Gastric or Esophagogastric Junction Adenocarcinoma Clinical Trials in Guangzhou, Guangdong

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma